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Abstract
Introduction: In previous studies, women are less aware of causation and symptoms of leprosy and have less
access to health care coverage than men, thus contributing to their delay in seeking for treatment. We assess the
gender differences in leprosy cases admitted to a rural referral hospital in Ethiopia for 7 and a half years.
Methods: Retrospective data of the leprosy patients admitted to referral hospital were collected using leprosy
admission registry books from September 2002 to January 2010. Variables were entered in an Excel 97 database.
Results: During the period of study, 839 patients with leprosy were admitted; 541 (64.5%) were male, and 298
(35.6%) female. Fifteen per cent of female patients, and 7.3% of male patients were paucibacillary leprosy cases
while 84.8% of female patients and 92.7% of males were multibacillary leprosy cases (p<0.001). Female leprosy
patients were younger than male ones (median: 36 versus 44 years) (p<0.001). In the multivariate analysis, age
(odds ratio [OR]: 0.97; 95% confidence interval [CI]: 0.96-0.98; p<0.001), admission for cardiovascular diseases
(OR: 7.6, 95% CI: 1.9-29.3; p=0.004), admission for gastroenteritis (OR: 14.0; 95% CI: 1.7-117; p=0.02), admission from
out patients clinic (OR: 2.04; 95% CI: 1.1-4.01; p=0.02), and mortality as final outcome (OR: 3.1, 95% CI: 1.2-8.0;
p=0.02) were independently associated with female gender.
Conclusions: Female patients with leprosy admitted to hospital were younger, had a different profile of admission
and a higher mortality rate than male ones.
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Introduction
Leprosy is a chronic disease with low-grade infectivity
caused by Mycobacterium leprae, that can lead to de-
formities, physical handicap, and social stigma [1]. Dur-
ing the 1990s and 2000s, leprosy services were
intensified in a World Health Organisation (WHO) sti-
mulated effort for reducing the burden of disease in
many endemic countries. A consequence of this is that
the number of registered leprosy cases has decreased
from 5 351 408 cases in 1985 to 926 259 cases in 1996
and 244 796 cases in 2009 [2-4]. The introduction of
multi-drug therapy (MDT) made possible that leprosy
patients could be diagnosed, treated and followed-up in
outpatient clinics. However, referral centres continue to
play a key role in providing specialized services for
patients with complications of the disease, such as lep-
rosy reaction, neuropathy or skin ulcer, as well as in the
prevention of disabilities and rehabilitation. Referral cen-
tres that are part of the general health-care system have
also been crucial in helping primary care [4].
In two cohorts of newly detected leprosy patients in
Bangladesh (The Bangladesh Acute Nerve Damage
Study [BANDS]) and Ethiopia (ALERT MDT Field
Evaluation Study [AMFES]), there were fewer women
diagnosed of leprosy than men (ratio female/male 0.6)
[5]. Moreover, women are less aware of causation and
symptoms of leprosy and have less access to health care
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coverage than men, thus contributing to their delay in
seeking for treatment [6-8]. Thus, understanding gender
differences in clinical presentation, type of leprosy, and
access to health of leprosy patients is important [9].
Also, female leprosy patients suffer more isolation and
rejection from society than males [1,10-12].
In this study, we analyse gender differences in clinical
and epidemiological characteristics and outcomes of lep-
rosy patients admitted to a long-term care rural referral
hospital in South-eastern Ethiopia.
Methods
Setting
The Gambo Rural Hospital (GRH) is a rural hospital in
Ethiopia (in the Oromiya region), which is a referral centre
in the programme of leprosy care in the country according
to the guidelines of Tuberculosis and Leprosy Prevention
and Control Programme (TLPCP) [13,14]. The GRH is
located in West-Arsi zone, 250 Km southeast of Addis
Ababa. Most of the population live in a rural setting and
work in agriculture and farming. In 1961 the Leprosy
Centre in Gambo begins its work. Later on (1966–1970),
the National Policy for Leprosy Services changes from
Leprosy Settlement to Leprosy Control Units or Stations.
Gambo Leprosy Centre becomes an Integrated Health
Unit catering to all health needs, including leprosy
patients, with a 49 beds dispensary. In 1985, the Gambo
Leprosy Control Centre changes its name to GRH. Several
leprosy cases treated in GRH continued living around the
hospital in Gambo leprosy village (about 250 families).
The diagnosis of leprosy is usually made with clinical
findings according to TLPCP [9,10]. According of
TLPCP, criteria for admission are severe erythema
nudoso leprosum (ENL) reaction, deep skin ulcer, red
and/or painful eye, pregnancy, tuberculosis or any other
severe infection, age younger than 12, recent history of
peptic ulcer in the stomach or duodenum, history of dia-
betes, general illness with fever, patients who did not im-
prove during a previous course of treatment and
patients who improved during previous course, but who
develop a reaction for the third time [13,14].
In Ethiopia there is a main referral hospital, ALERT
Hospital, in Addis Abeba where patients were transferred
from different first level leprosy care and from peripheral
referral leprosy hospitals [15]. There are 5 referral leprosy
hospitals in Ethiopia and GRH is one of them.
All leprosy patients with medical and surgical pro-
blems who need hospital admission related or not with
leprosy are admitted to the leprosy ward in GRH. The
patients stay in hospital until recovery of their problems.
The cost of hospitalization is free for them. The food is
provided by the hospital. After being discharged, the
patients may continue attending the GRH clinic or are
transferred to other clinics near their homes.
Study design and data collection
Diagnosis of leprosy is usually made in the GRH with
clinical examination according to TLPCP [13,14].
Patients who are diagnosed as new or old leprosy cases
at GRH are: 1) admitted to hospital in the case of ser-
iously ill leprosy patients, 2) registered at the GRH lep-
rosy clinic or 3) referred to leprosy clinics near their
home. A retrospective data collection from all the
patients diagnosed of leprosy and admitted to the lep-
rosy ward was done using the admission registry book.
Patients were classified according to the number of lep-
rosy skin lesions and the result of the skin smear exam-
ination as: multibacillary (MB) leprosy (six or more skin
lesions or less than six skin lesions which have a positive
slit skin smear result) or paucibacillary (PB) leprosy (one
to five leprosy skin lesions [13,14].
The health workers completed the admitting forms,
which included variables of age, sex, place of residence,
case definitions, WHO classification of leprosy (MB or
PB leprosy), origin of admission, length of hospital stay,
diagnosis during admission, and outcome.
Case definitions were: (1) new case: a patient with MB
or PB leprosy who has never received treatment for lep-
rosy before, (2) a patients who relapses after MDT: a pa-
tient properly treated with a complete course of MDT,
but who returns to the health service and is found to
have active leprosy again; (3) return after withdrawal: an
MB patient who returns for treatment, after having
missed more than 3 four-weekly doses of MDT; and (4)
transfer in: a patient who started treatment in one health
setting and moved to another to continue treatment.
Origin of admission: field (if the patients was admitted
from other leprosy clinic); outpatients (OPD) depart-
ment (if the patients was admitted from the OPD de-
partment). Diagnosis during admission was made using
standardised definitions. Definitions of outcome during
admission: (1) improved: a patient who has improved
within the admission period, (2) died: a patients who
dies of any cause, (3) not improvement: a patient who
does not improve, or (4) run away: a patient who leaves
voluntarily the hospital.
The period analysed in the study began in September
2002 and ended in January 2010, (seven and a half
years). Re-admission data were only available for admis-
sions from 1st December 2004 to 31st January 2010. The
ethics committee approvals were obtained from the
local Research and Publication Committee of the GRH,
and Health Unit and Ethical Review Committee of the
Ethiopian Catholic Secretary.
Statistical analysis
Epidemiological and clinical data were entered in an
Excel 97 database. Statistical analysis were performed
with the use of SPSS software, version 12. Continuous
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variables are given as median, range, and interquartile
range (IQR). Chi-square test was used for comparison
between two groups of subjects (male and female),
Fisher’s exact test was used in the case the sample size
of patients wasn`t large enough, and Kruskal-Wallis
test, a nonparametric test, was used to compare the
significance of the difference between the distributions of
two independent samples. Each category was analysed
in a univariate way. Univariate predictors with p-value
< 0.25 were included in a logistic regression model to
identify independent variables associated with gender
by odds ratio (OR) with a 95% confidence interval
(CI).
Results
In the seven and a half years period, 839 patients with
leprosy were admitted to GRH with an average of 100
cases per year. Among them, 541 (64.5%) were male,
and 298 (35.6%) female. The male/female ratio of admit-
ted patients was 1.8. Two hundred and forty four
(29.1%) patients were living in the catchment area of the
GRH. Female leprosy patients were living in the catch-
ment area more than male leprosy patients (37.6% ver-
sus. 24.4%, p<0.001). The median age of study
population was 40 years (IQR: 25 – 55). Twenty-seven
(3.2%) were children (under 15 years old). Female lep-
rosy patients were younger (median age: 36 years) than
male ones (median age: 44 years; p<0.001) (Table 1).
Forty-seven per cent in the female group, and 35.9% in
the male group were included in the 19 to 35 age inter-
val (p=0.005), and 39.9% of female patients, and 55.5%
of male patients were older than 35 year-old (p<0.001).
Data from re-admission were only available for 519
cases. There were 84 (16.2%) cases of readmission with-
out differences by gender. The median of readmissions
per patient was 2 times (range: 2–8). The main charac-
teristics of these individuals by gender are shown in
Table 2. Thirty nine percent of female lived and 24.4% of
male lived in the catchment area (p<0.001). Fifteen per
cent of female and 7.3% of male were PB leprosy cases
while 84.8% of female, and 92.7% of male were MB lep-
rosy cases (p<0.001). The prevalence of new MB, and
new PB cases was similar in women and men (16.6%
versus 13.2%, and 2.0% versus 1.1%, respectively). How-
ever, the prevalence of old MB cases was significantly
lower in female (68.2%) than in male ones (79.6%), with
old PB cases being more common in female ones
(13.2%) than in male (6.1%) (p=0.001). There was no dif-
ference by gender in the prevalence of patients on MDT.
Female leprosy patients were admitted from the OPD in
95.6% of the cases, and from the “field” in only 4.4%;
among male leprosy patients, admission was made from
the OPD in 93.8%, and from the “field” in 8.7% (p=0.03).
The main diagnosis after discharge was neuropathic
skin ulcer (56.2%). The diagnosis of neuropathic skin
ulcer was performed in 48.3% of women and 60.5% of
men (p=0.001). The other mainly diagnoses during the
admission were: reversal reaction, neuritis, osteomyelitis,
ENL, and lower respiratory tract infection without differ-
ences by gender as shown in Table 3. Differences of
prevalence between female and male were found in diag-
nosis of cases not related with leprosy, such as cardio-
vascular disease (3.4% versus 0.6%; p=0.004) or
gastroenteritis (2.8% versus 0.1%; p=0.002), being the
prevalence of these diseases very low in the sample.
The median length of hospital stay was 65 days (IQR:
36–111) (Table 1). There was no difference between
both groups. The majority of patients recovered un-
eventfully (90.6%), with no statistical differences between
men and women. Only 4.6% of the sample was referred
to other hospitals. The hospital mortality was low
(2.8%), slightly higher in female than in male patients
(4.3% versus 2.0%; p=0.07). Other outcomes are shown
in Table 3.
In the multivariate analysis, age (OR: 0.97; 95% CI:
0.96-0.98; p<0.001) was inversely associated with female
gender, in contrast admission from the OPD (OR: 2.4,
95%: CI 1.1-4.0; p=0.03; versus field admission), and
mortality as final outcome (OR: 3.1, 95% CI: 1.2-8.0;
p=0.02) were directly associated with female gender
(Table 4).
Discussion
In Ethiopia, since the introduction of MDT for leprosy
patients, leprosy control was incorporated as an aim
within the general health service system [7]. A referral
system could play a crucial role in ensuring the quality
of services in an integrated leprosy control programme
[13,14]. This study analyzed inpatients with leprosy in a
rural referral hospital and found significant differences
by gender.
Table 1 Median, range and interquartile range (IQR) of age and days of admission in female and male leprosy patients
Missing Total Male Female P value
Median Range/IQR Median Range/IQR Median Range/IQR
Age, years M:0; F:0 40 4-81/25-55 44 9-81/28-57 36 4-77/24-50 <0.001
Duration of hospital stay, days M: 16; F:13 65 2- 550/36-111 68 2-550/40-108 60 1- 490/28-113 0.69
M: male; F: female.
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Traditionally, the preponderance of male patients over
female ones has been reported [5-8]. In the current
study, the ratio male/female in admitted leprosy patients
(1.8) was slightly lower than the observed in a new cases
sample diagnosed in our centre previously (2.1) [16].
This fact agrees with previous studies conducted in
other African countries [5,6,8,17]. However there are
studies with a similar proportion of men/and women
[18,19], and others where the ratio is as high as 3:1
[20,21]. In our study the ratio male/female in admitted
leprosy patients was 1.8, however in a recent national
demographic survey [22], carried on by the Ethiopian
Ministry of Health, the amount of men in an aleatory
sample that was representative of almost 18.000 house-
holds in the whole country was inferior to the amount
of women. In Ethiopia and in Oromiya region, the ratio
of men to women was 0.78 and 0.83, respectively, so, in
our study, the rate male/female is not biased toward
males.
Female patients admitted were younger than male
patients. Arora et al. [20] in a study performed in cases
diagnosed in a tertiary care centre in India found leprosy
more prevalence in female than in male in the age group
ranged 15 to 35 years, suggesting that hormonal imbal-
ance related to pregnancy/puerperium, might play a role.
This peak incidence observed in women in the fertile
age group has also been reported in other studies [23].
Female patients live in the catchment area more often
than male patients, though is not seen in the multivari-
ate analysis. It might be explained by the reason that
male patients have more incomes, and they are more
likely to afford to travel further to get care. But, this
Table 2 Main epidemiological and clinical characteristics, and outcome in female and male leprosy patients
Variables Missing Total Male Female Chi- square value P value
N % N % N %
Origin M:0; F:0 16.2 <0.001
Catchment area 244 29.1 132 24.4 112 37.8
Outside catchment area 595 70.9 409 75.6 186 62.2
Age M:0; F:0
< 18 89 10.6 47 8.7 42 14.1 5.88 0.020
19-35 331 39.5 194 35.9 137 46.0 8.21 0.005
> 35 419 49.9 300 55.5 119 39.9 18.12 <0.001
Re-admission M: 204; F: 114 0.09 0.82
Yes 84 16.2 53 15.8 31 16.8
No 435 83.8 282 84.2 153 83.2
WHO classification M:1; F:2 13.49 <0.001
PB 84 10.0 39 7.3 45 15.2
MB 752 90.0 501 92.7 251 84.8
On MDT M:1; F:2 2.68 010
Yes 132 15.7 78 14.3 55 18.6
No 710 84.3 461 85.7 237 81.4
Old or New cases M:1; F:2
New MB 120 14.3 71 13.2 49 16.6 1.81 0.21
New PB 12 1.4 6 1.1 6 2.0 0.02 0.99
Old MB 632 75.6 430 79.6 202 68.2 13.41 <0.001
Old PB 72 8.6 33 6.1 39 13.2 12.13 0.001
Admission from M:0; F:0 5.39 0.03
OPD 779 92.8 494 91.3 285 95.6
Field 60 7.2 47 8.7 13 4.4
Outcome M:37; F:21
Improved 707 90.6 459 91.0 248 89.6 0.49 0.56
Referred 36 4.6 25 5.0 11 4.0 0.30 0.65
Death 22 2.8 10 2.0 12 4.3 3.60 0.09
Not improved 8 1.0 4 0.8 4 1.4 0.29 0.62
Voluntary discharged 8 1.0 6 1.2 2 0.7 0.05 0.80
M: male; F: female; MDT multidrug therapy; MB: multibacillary; PB: paucibacillary; OPD: outpatients department.
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question is not possible to answer with the type of de-
sign of this study.
The prevalence of MB leprosy cases admitted to hos-
pital was lower in the female group than in the male
one. However, the effect of WHO leprosy classification
was not significant after adjustment for other variables
including age. The prevalence of MB leprosy in male
patients has been reported to be higher than in female
ones in different series of new cases diagnosed in
endemic countries such as Nigeria, Indonesia, Brazil,
Nepal and Malawi [6,18-21].
Chronic skin ulcers are among the most serious com-
plications of leprosy [24]. In our study, the main diagno-
sis during admission to hospital was neuropathic skin
ulcer in lower extremities associated with infection or
osteomyelitis. Neuropathic skin ulcers are one of the
most common sequelae of leprosy and can result in large
economic and social burden [25,26]. In our study, this
diagnosis was less common in women than in men ad-
mitted to hospital in the univariate analysis. A descrip-
tive cross-sectional study conducted in 245 leprosy
patients with infected ulcers visiting three Ethiopian
hospitals (ALERT, Kuyera and GRH) from August 2006
to May 2007 found an incidence of ulcers of 64.1% in
men and 35.9% in women [24]. Similar results have been
reported in other studies [27,28]. Britton and Lockwood
[29] described this predominance, as true difference be-
tween men and women. This is not because of being
underdiagnosed in women, but in some countries it was
noticed by the delayed presentation of female patients,
which results in high deformity.
Admissions for medical problems associated with lep-
rosy, such as leprorreaction, or neuritis were similar in
Table 3 Diagnosis during hospital admission in female and male leprosy patients
Total Male Female Chi- square value P value
M:2; F:6 N % N % N %
Infected skin ulcer 467 56.2 326 60.5 141 48.3 11.52 0.001
Reversal reaction 80 9.6 48 8.9 32 10.9 0.80 0.40
Neuritis 72 8.7 49 9.1 23 7.9 0.30 0.64
Osteomyelitis 68 8.2 47 8.7 21 7.2 0.10 0.81
ENL 46 5.5 29 5.4 17 5.8 0.03 0.91
LRTI 31 5.7 17 3.1 14 4.8 0.50 0.32
Cellulitis 16 1.9 9 1.7 7 2.4 0.30 0.64
Diabetes mellitus 13 1.6 9 1.7 4 1.4 0.04 0.97
Cardiovascular diseases 13 1.6 3 0.6 10 3.4 9.92 0.004
Gastroenteritis 9 1.1 1 0.2 8 2.7 11.29 0.002
Accident 7 0.8 4 0.7 3 1.0 0.20 0.70
Chronic liver diseases 7 0.8 2 0.4 5 1.7 3.1 0.06
Tuberculosis 6 0.7 5 0.9 1 0.3 0.30 0.60
Arrhythmia 5 0.6 4 0.7 1 0.3 0.35 0.66
Eyes problems 5 0.6 1 0.2 4 1.4 3.3 0.05
Peptic ulcer 5 0.6 1 0.2 4 1.4 3.2 0.06
Intestinal parasites 5 0.6 3 0.6 2 0.7 0.01 0.99
Mental disorders 4 0.5 1 0.2 3 1.0 2.5 0.12
Neoplasm 3 0.4 3 0.6 0 0.0 0.5 0.31
Urinary tract infection 3 0.4 3 0.6 0 0.0 0.5 0.30
Others 12 1.4 7 1.3 5 1.7 - -
Total* 831 100 539 100 292 100 - -
M: male; F: female; ENL: erythema nodosum leprosum; LRTI: lower respiratory tract infection.
* Because each patient could have >1 diagnosis, the number of cases can be higher than the number of patients.
Table 4 Variables associated with female gender in a
multivariate analysis*
OR 95% CI P value
Age 0.97 0.96 - 0.98 <0.001
Admission for cardiovascular diseases 7.6 1.9 - 29.3 0.004
Admission from the OPD 2.4 1.1 - 4.0 0.03
Admission for gastroenteritis 14.0 1.7-117 0.02
Died as final outcome 3.1 1.2 - 8.0 0.02
NOTE: OR: odds ratio; 95% confidence intervals (CI); OPD: outpatient clinic.
* Variables with p-value < 0.25 in univariate analysis were included in the
logistic regression model. They were: origin of patients, age of patients WHO
classification, old or new paucibacillary or multibacillary leprosy cases,
admission from field or OPD, died as final outcome, and infected skin ulcer,
cardiovascular diseases, gastroenteritis, chronic liver diseases, eyes problems,
peptic ulcer, and mental disorder as cause of admission.
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the female and male groups. In this regard, admissions
for other diagnosis, apparently unrelated to leprosy, such
as cardiovascular diseases (p.e. chronic heart failure or
stroke) or gastroenteritis were more common in women
than in men.
Leprosy per se is not fatal [30], death among active
patients can be regarded as an unusual event, in our
study approximately 3 percent died. Although the overall
death rate in the sample was very low, we observed dif-
ferences in fatality rates by gender. Fatal cases were
more common in women than in men in multivariate
analysis, finding that might be related to the comorbidity
pattern leading to hospital admission.
Several limitations should be considered in this study.
Due to the fact that it was retrospectively conducted
with data collected from a registry book, some of our
data are incomplete, including co-morbidities and
neurological assessments. Moreover, the re-admission
rate was recorded in less than two thirds of patients
admitted.
Conclusions
Despite these limitations, we understand that the charac-
teristics of women admitted in our institution are differ-
ent than in men, they were younger, had a different
profile of admission and a higher mortality rate than
male ones. However, with our results it is not able to get
other conclusions about gender relation with the access
to health care coverage, the delay in seeking for care and
the isolation and rejection from the society.
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